Home › Asset managers › Aberdeen › 2023-2024 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Aberdeen voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
1,441 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Aberdeen voted | Funds |
|---|---|---|---|---|---|---|---|
| MERCK & CO. INC. | May 28, 2024 | Non-binding advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 12 | |
| UNITEDHEALTH GROUP INC. | June 3, 2024 | Advisory approval of the Company's executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 12 | |
| ABBVIE INC. | May 3, 2024 | Say on Pay - An advisory vote on the approval of executive compensation | Say-on-Pay | Board (inferred) | AGAINST | 10 | |
| BRISTOL-MYERS SQUIBB CO. | May 7, 2024 | Advisory Vote to Approve the Compensation of our Named Executive Officers | Say-on-Pay | Board (inferred) | AGAINST | 10 | |
| NEXTERA ENERGY INC. | May 23, 2024 | Approval, by non-binding advisory vote, of Nextera Energy's compensation of its named executive officers as disclosed in the proxy statement | Say-on-Pay | Board (inferred) | AGAINST | 10 | |
| CMS ENERGY CORP. | May 3, 2024 | Approve, on an advisory basis, the Company's executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 9 | |
| FIRSTENERGY CORP. | May 22, 2024 | Approve, on an Advisory Basis, Named Executive Officer Compensation | Say-on-Pay | Board (inferred) | AGAINST | 9 | |
| NORFOLK SOUTHERN CORP. | May 9, 2024 | Approval of the advisory resolution on executive compensation, as disclosed in the Norfolk Southern's proxy statement for the 2024 Annual Meeting. | Say-on-Pay | Board (inferred) | AGAINST | 9 | |
| WASTE MANAGEMENT INC. | May 14, 2024 | Approval, on an advisory basis, of our executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 9 | |
| AMGEN INC. | May 31, 2024 | Advisory vote to approve our executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 8 | |
| ANALOG DEVICES INC. | March 13, 2024 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 8 | |
| ASTRAZENECA PLC | April 11, 2024 | Amend Performance Share Plan 2020 | Compensation | Board | AGAINST | 8 | |
| ASTRAZENECA PLC | April 11, 2024 | Approve Remuneration Policy | Compensation | Board | AGAINST | 8 | |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC. | May 8, 2024 | Advisory Approval of 2023 Executive Officer Compensation | Say-on-Pay | Board (inferred) | AGAINST | 8 | |
| DANAHER CORP. | May 7, 2024 | To approve on an advisory basis the Company's named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 8 | |
| ELI LILLY AND CO. | May 6, 2024 | Election of the following directors, each to serve a three-year term: J. Erik Fyrwald | Director Elections | Board | AGAINST | 8 | |
| ELI LILLY AND CO. | May 6, 2024 | Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2024. | Audit-related | Board | AGAINST | 8 | |
| ELI LILLY AND CO. | May 6, 2024 | Shareholder proposal to publish an annual report disclosing lobbying activities. | Other Social Issues | Shareholder | Against | FOR | 8 |
| GAMING AND LEISURE PROPERTIES INC. | June 13, 2024 | To approve, on a non-binding advisory basis, the Company's executive compensation. | Say-on-Pay | Board | AGAINST | 8 | |
| GILEAD SCIENCES INC. | May 8, 2024 | To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. | Say-on-Pay | Board (inferred) | AGAINST | 8 | |
| ILLUMINA INC. | May 16, 2024 | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. | Say-on-Pay | Board (inferred) | AGAINST | 8 | |
| LINDE PLC | July 24, 2023 | To approve, on an advisory and non-binding basis, the compensation of Linde plc's Named Executive Officers, as disclosed in the 2023 Proxy statement | Say-on-Pay | Board (inferred) | AGAINST | 8 | |
| MERCK & CO. INC. | May 28, 2024 | Election of Directors: Patricia F. Russo | Director Elections | Board | AGAINST | 8 | |
| MERCK & CO. INC. | May 28, 2024 | Election of Directors: Thomas H. Glocer | Director Elections | Board | AGAINST | 8 | |
| MERCK & CO. INC. | May 28, 2024 | Ratification of the appointment of the Company's independent registered public accounting firm for 2024. | Audit-related | Board | AGAINST | 8 | |
| MICROSOFT CORP. | December 7, 2023 | Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote") | Say-on-Pay | Board (inferred) | AGAINST | 8 | |
| MODERNA INC. | May 6, 2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 8 | |
| THERMO FISHER SCIENTIFIC INC. | May 22, 2024 | An advisory vote to approve named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 8 | |
| UNITEDHEALTH GROUP INC. | June 3, 2024 | Election of Directors: Michele Hooper | Director Elections | Board | AGAINST | 8 | |
| UNITEDHEALTH GROUP INC. | June 3, 2024 | Election of Directors: Stephen Hemsley | Director Elections | Board | AGAINST | 8 | |
| UNITEDHEALTH GROUP INC. | June 3, 2024 | If properly presented at the 2024 Annual Meeting of Shareholders, the shareholder proposal requiring a political contributions congruency report. | Other Social Issues | Shareholder | Against | FOR | 8 |
| UNITEDHEALTH GROUP INC. | June 3, 2024 | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2024. | Audit-related | Board | AGAINST | 8 | |
| VERTEX PHARMACEUTICALS INC. | May 15, 2024 | Advisory vote to approve named executive office compensation. | Say-on-Pay | Board (inferred) | AGAINST | 8 | |
| ABBOTT LABORATORIES | April 26, 2024 | Say on Pay - An Advisory Vote on the Approval of Executive Compensation | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| AMERICAN TOWER CORP. | May 22, 2024 | To consider a stockholder proposal, if properly presented, regarding disclosure of racial and gender pay gaps. | Diversity, Equity, and Inclusion | Shareholder | Against | FOR | 7 |
| AMERICAN TOWER CORP. | May 22, 2024 | To elect the following Directors: JoAnn A. Reed | Director Elections | Board | AGAINST | 7 | |
| AMERICAN TOWER CORP. | May 22, 2024 | To elect the following Directors: Pamela D. A. Reeve | Director Elections | Board | AGAINST | 7 | |
| AMERICAN TOWER CORP. | May 22, 2024 | To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2024. | Audit-related | Board | AGAINST | 7 | |
| APPLE INC. | February 28, 2024 | Advisory vote to approve executive compensation | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| APTIV PLC | April 24, 2024 | Say-on-Pay - To approve, by advisory vote, executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| AVANTOR INC. | May 9, 2024 | Approve, on an Advisory Basis, Named Executive Officer Compensation. | Say-on-Pay | Board | AGAINST | 7 | |
| BANK OF AMERICA CORP. | April 24, 2024 | Approving our executive compensation (an advisory, non-binding "Say on Pay" resolution) | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| BAXTER INTERNATIONAL INC. | May 7, 2024 | Advisory vote to Approve Named Executive Officer Compensation | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| BECTON, DICKINSON AND CO. | January 23, 2024 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| BOSTON SCIENTIFIC CORP. | May 2, 2024 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| BROADCOM INC. | April 22, 2024 | Advisory vote to approve the named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| CATALENT INC. | January 25, 2024 | Advisory Vote to Approve Our Executive Compensation. (Say-on-Pay). | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| CENTERPOINT ENERGY INC. | April 26, 2024 | Approve the advisory resolution on executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| CISCO SYSTEMS INC. | December 6, 2023 | Approval, on an advisory basis, of executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| CME GROUP INC. | May 9, 2024 | Advisory vote on the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| COCA-COLA CO. | May 1, 2024 | Advisory vote to approve executive compensation | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| DEXCOM INC. | May 22, 2024 | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2023. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| EDWARDS LIFESCIENCES CORP. | May 7, 2024 | Advisory Vote to Approve Named Executive Officer Compensation | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| FEDEX CORP. | September 21, 2023 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| FIDELITY NATIONAL INFORMATION SERVICES INC. | June 5, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| HCA HEALTHCARE INC. | April 25, 2024 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| HUMANA INC. | April 18, 2024 | Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2024 proxy statement. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| IDEXX LABORATORIES INC. | May 6, 2024 | Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| INTUITIVE SURGICAL INC. | April 25, 2024 | To approve, by advisory vote, the compensation of the Company's Named Executive Officers. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| IQVIA HOLDINGS INC. | April 16, 2024 | Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay). | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| KEURIG DR PEPPER INC. | June 10, 2024 | To approve, on an advisory basis, Keurig Dr Pepper Inc.'s executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| LAS VEGAS SANDS CORP. | May 9, 2024 | An advisory (non-binding) vote to approve the compensation of the named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| LOWE'S COMPANIES INC. | May 31, 2024 | Advisory vote to approve the Company's named executive officer compensation in fiscal 2023. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| MEDTRONIC PLC | October 19, 2023 | Approving, on an advisory basis, the Company's executive compensation; | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| METLIFE INC. | June 18, 2024 | Advisory (non-binding) vote to approve the compensation paid to MetLife, Inc.'s Named Executive Officers | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| MOLINA HEALTHCARE INC. | May 1, 2024 | To consider and approve, on a non-binding, advisory basis the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| MONDELEZ INTERNATIONAL INC. | May 22, 2024 | To approve, on an advisory basis, the Company's executive compensation; | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| NEWMONT CORP. | April 24, 2024 | Approval of the advisory resolution on Newmont's executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| NEXTERA ENERGY PARTNERS LP | April 22, 2024 | Approval, by non-binding advisory vote, of the compensation of NextEra Energy Partners' named executive officers as disclosed in the proxy statement | Say-on-Pay | Board | AGAINST | 7 | |
| PFIZER INC. | April 25, 2024 | 2024 advisory approval of executive compensation | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| STANLEY BLACK & DECKER INC. | April 26, 2024 | Approve, on an advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| STRYKER CORP. | May 9, 2024 | Advisory Vote to Approve Named Executive Officer Compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| TARGET CORP. | June 12, 2024 | Company proposal to approve, on an advisory basis, our executive compensation (Say on Pay). | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| TETRA TECH INC. | February 29, 2024 | To approve, on an advisory basis, the Company's named executive officers' compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| WEST PHARMACEUTICAL SERVICES INC. | April 23, 2024 | Advisory vote to approve named executive officer compensation; | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| ZIMMER BIOMET HOLDINGS INC. | May 10, 2024 | Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay"). | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| ZOETIS INC. | May 22, 2024 | Advisory vote to approve our executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 7 | |
| ABBVIE INC. | May 3, 2024 | Stockholder Proposal - to Issue a Report on Patent Process | Other Social Issues | Shareholder | Against | FOR | 6 |
| ACCTON TECHNOLOGY CORP. | June 13, 2024 | Elect a Representative of KUAN XIN INVESTMENT CORP., with Shareholder No. 0248318, as Non-independent Director | Director Elections | Board | AGAINST | 6 | |
| AGILENT TECHNOLOGIES INC. | March 14, 2024 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 6 | |
| AMERICAN ELECTRIC POWER COMPANY INC. | April 23, 2024 | Advisory approval of the Company's executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 6 | |
| AMERICAN WATER WORKS COMPANY INC. | May 15, 2024 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 6 | |
| CHINA TOURISM GROUP DUTY FREE CORPORATION LTD. | May 23, 2024 | Approve Ernst & Young Hua Ming LLP ("EY Hua Ming") as Domestic Financial Reporting Auditors and Ernst & Young ("EY Hong Kong") as International Financial Reporting Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 6 | |
| CHINA TOURISM GROUP DUTY FREE CORPORATION LTD. | May 23, 2024 | Approve Ernst & Young Hua Ming LLP ("EY Hua Ming") as Internal Control Auditor and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 6 | |
| CIGNA GROUP | April 24, 2024 | Advisory approval of The Cigna Group's executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 6 | |
| CONTEMPORARY AMPEREX TECHNOLOGY CO. LTD. | April 19, 2024 | Approve Application of Credit Lines | Capital Structure | Board | AGAINST | 6 | |
| CONTEMPORARY AMPEREX TECHNOLOGY CO. LTD. | April 19, 2024 | Approve Estimated Amount of Guarantees | Capital Structure | Board | AGAINST | 6 | |
| ELEVANCE HEALTH INC. | May 15, 2024 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 6 | |
| HEALTHPEAK PROPERTIES INC. | April 25, 2024 | Approval of 2023 executive compensation on an advisory basis. | Say-on-Pay | Board (inferred) | AGAINST | 6 | |
| HUBBELL INC. | May 7, 2024 | To approve, by non-binding vote, the compensation of our named executive officers as presented in the 2024 Proxy Statement. | Say-on-Pay | Board (inferred) | AGAINST | 6 | |
| NEXTERA ENERGY INC. | May 23, 2024 | A proposal entitled "Board Matrix" requesting a chart of individual Director self-identified gender, race/ethnicity and skills | Diversity, Equity, and Inclusion | Shareholder | Against | FOR | 6 |
| NEXTERA ENERGY INC. | May 23, 2024 | A proposal entitled "Climate Lobbying Report" requesting a report on the Company's lobbying and trade association memberships in relation to the Company's emissions goal | Environment or Climate | Shareholder | Against | FOR | 6 |
| NEXTERA ENERGY INC. | May 23, 2024 | Election as Directors of the nominees specified in the proxy statement: James L. Camaren | Director Elections | Board | AGAINST | 6 | |
| NEXTERA ENERGY INC. | May 23, 2024 | Ratification of appointment of Deloitte & Touche LLP as NextEra Energy's independent registered public accounting firm for 2024 | Audit-related | Board | AGAINST | 6 | |
| PPL CORP. | May 15, 2024 | Advisory vote to approve compensation of named executive officers | Say-on-Pay | Board (inferred) | AGAINST | 6 | |
| PROCTER & GAMBLE CO. | October 10, 2023 | Advisory Vote to Approve the Company's Executive Compensation (the "Say on Pay" vote) | Say-on-Pay | Board (inferred) | AGAINST | 6 | |
| PT TELKOM INDONESIA (PERSERO) TBK | May 3, 2024 | Approve Changes in the Boards of the Company | Director Elections | Board | AGAINST | 6 | |
| RESMED INC. | November 16, 2023 | Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay"). | Say-on-Pay | Board | AGAINST | 6 | |
| SIMON PROPERTY GROUP INC. | May 8, 2024 | Advisory Vote to Approve the Compensation of our Named Executive Officers. | Say-on-Pay | Board (inferred) | AGAINST | 6 | |
| TOTALENERGIES SE | May 24, 2024 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights and/or Capitalization of Reserves for Bonus Issue or Increase in Par Value, up to Aggregate Nominal Amount of EUR 2.5 Billion | Capital Structure | Board | AGAINST | 6 |
Page 1 of 15 Next →
← Back to Aberdeen 2023-2024 overview
Built October 18, 2026 from SEC Form N-PX filings.